Inventor
MURALI RAMACHANDRAN
US45 patents
⚠️ This page may combine multiple inventors who share the name “MURALI RAMACHANDRAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
23 patentsUS6673771B1Jan 6, 2004
Methods of inhibiting osteoclast activity
UNIV PENNSYLVANIA43 citations96
US6417168B1Jul 9, 2002
Compositions and methods of treating tumors
UNIV PENNSYLVANIA120 citations96
US8765810B2Jul 1, 2014
Tumor necrosis factor inhibitors
UNIV PENNSYLVANIA46 citations95
US7625558B2Dec 1, 2009
Compositions and methods of treating tumors
UNIV PENNSYLVANIA43 citations94
US6265535B1Jul 24, 2001
Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
UNIV PENNSYLVANIA54 citations94
US7662374B2Feb 16, 2010
Monoclonal antibodies to activated erbB family members and methods of use thereof
UNIV PENNSYLVANIA36 citations93
US7906624B2Mar 15, 2011
Binding peptidomimetics and uses of the same
UNIV PENNSYLVANIA9 citations84
US7653495B1Jan 26, 2010
Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
UNIV PENNSYLVANIA10 citations84
US7638598B2Dec 29, 2009
ErbB interface peptidomimetics and methods of use thereof
UNIV PENNSYLVANIA10 citations82
US7179785B2Feb 20, 2007
Compounds that bind to p185 and methods of using the same
UNIV PENNSYLVANIA7 citations73
US7781566B2Aug 24, 2010
ErbB interface peptidomimetics and methods of use thereof
UNIV PENNSYLVANIA4 citations72
US6682739B1Jan 27, 2004
Methods of inhibiting osteoclastogenesis
UNIV PENNSYLVANIA8 citations69
US8022176B2Sep 20, 2011
FAS peptide mimetics and uses thereof
UNIV PENNSYLVANIA1 citations63
US8019557B2Sep 13, 2011
Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
UNIV PENNSYLVANIA2 citations63
US7288519B2Oct 30, 2007
Fas peptide mimetics and uses thereof
UNIV PENNSYLVANIA2 citations63
US7745577B2Jun 29, 2010
Compounds that bind to P185 and methods of using the same
UNIV PENNSYLVANIA2 citations62
US7566741B2Jul 28, 2009
Methods of inhibiting osteoclast activity
UNIV PENNSYLVANIA2 citations62
US8962793B2Feb 24, 2015
ErbB interface peptidomimetics and methods of use thereof
UNIV PENNSYLVANIA2 citations61
US8003628B2Aug 23, 2011
Methods of inhibiting osteoclast activity
UNIV PENNSYLVANIA0 citations52
US7998924B2Aug 16, 2011
Compounds that bind to p185 and methods of using the same
UNIV PENNSYLVANIA0 citations52
US10583166B2Mar 10, 2020
Antigen-binding proteins comprising recombinant protein scaffolds
UNIV PENNSYLVANIA0 citations51
US9695252B2Jul 4, 2017
Antigen-binding proteins comprising recombinant protein scaffolds
UNIV PENNSYLVANIA0 citations51
US9096607B2Aug 4, 2015
Tumor necrosis factor inhibitors
UNIV PENNSYLVANIA0 citations49
CEDARS SINAI MEDICAL CENTER
9 patentsUS11529338B2Dec 20, 2022
Compositions and methods for treating cancer
CEDARS SINAI MEDICAL CENTER2 citations69
US10927070B2Feb 23, 2021
Compositions and methods for treating cancer
CEDARS SINAI MEDICAL CENTER3 citations69
US10029997B2Jul 24, 2018
Compositions and methods for treating cancers
CEDARS SINAI MEDICAL CENTER2 citations68
US12421185B2Sep 23, 2025
Compositions and methods for treating cancer
CEDARS SINAI MEDICAL CENTER0 citations59
US11547738B2Jan 10, 2023
Compositions and methods for treating fibrosis
CEDARS SINAI MEDICAL CENTER0 citations57
US10245298B2Apr 2, 2019
Compositions and methods for treating fibrosis
CEDARS SINAI MEDICAL CENTER1 citations57
US10881641B2Jan 5, 2021
Methods and use of compounds that bind to RelA of NF-kB
CEDARS SINAI MEDICAL CENTER0 citations53
US10836735B2Nov 17, 2020
Compositions and methods for treating cancers
CEDARS SINAI MEDICAL CENTER0 citations48
US10266505B2Apr 23, 2019
Compositions and methods for treating cancers
CEDARS SINAI MEDICAL CENTER0 citations48
GREENE MARK I
7 patentsUS8728479B2May 20, 2014
Antigen-binding proteins comprising recombinant protein scaffolds
GREENE MARK I21 citations91
US8680047B2Mar 25, 2014
Fas peptide mimetics and uses thereof
GREENE MARK I7 citations84
US8445644B2May 21, 2013
ErbB interface peptidomimetics and methods of use thereof
GREENE MARK I1 citations61
US8057799B2Nov 15, 2011
ErbB interface peptidomimetics and methods of use thereof
GREENE MARK I2 citations61
US9265739B2Feb 23, 2016
Methods and use of compounds that bind to HER2/neu receptor complex
GREENE MARK I0 citations52
US8993634B2Mar 31, 2015
Methods and use of compounds that bind to Her2/neu receptor complex
GREENE MARK I0 citations52
US8318699B2Nov 27, 2012
Tumor necrosis factor inhibitors
GREENE MARK I0 citations49